Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 2
2016 2
2017 3
2018 5
2019 7
2020 19
2021 12
2022 4
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer.
Mohanty A, Nam A, Srivastava S, Jones J, Lomenick B, Singhal SS, Guo L, Cho H, Li A, Behal A, Mirzapoiazova T, Massarelli E, Koczywas M, Arvanitis LD, Walser T, Villaflor V, Hamilton S, Mambetsariev I, Sattler M, Nasser MW, Jain M, Batra SK, Soldi R, Sharma S, Fakih M, Mohanty SK, Mainan A, Wu X, Chen Y, He Y, Chou TF, Roy S, Orban J, Kulkarni P, Salgia R. Mohanty A, et al. Among authors: mambetsariev i. Sci Adv. 2023 Oct 13;9(41):eade3816. doi: 10.1126/sciadv.ade3816. Epub 2023 Oct 13. Sci Adv. 2023. PMID: 37831779 Free PMC article.
Clinical Network Systems Biology: Traversing the Cancer Multiverse.
Mambetsariev I, Fricke J, Gruber SB, Tan T, Babikian R, Kim P, Vishnubhotla P, Chen J, Kulkarni P, Salgia R. Mambetsariev I, et al. J Clin Med. 2023 Jul 7;12(13):4535. doi: 10.3390/jcm12134535. J Clin Med. 2023. PMID: 37445570 Free PMC article. Review.
Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma.
Garcia D, Mambetsariev I, Fricke J, Schmolze D, Afkhami M, Mannan R, Kim P, Therese Dingal S, Nguyen B, Babikian R, Fong Y, Salgia R. Garcia D, et al. Among authors: mambetsariev i. Cold Spring Harb Mol Case Stud. 2023 May 9;9(2):a006262. doi: 10.1101/mcs.a006262. Print 2023 Apr. Cold Spring Harb Mol Case Stud. 2023. PMID: 37160318 Free PMC article.
Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy.
Sayer MR, Mambetsariev I, Lu KH, Wong CW, Duche A, Beuttler R, Fricke J, Pharoan R, Arvanitis L, Eftekhari Z, Amini A, Koczywas M, Massarelli E, Roosan MR, Salgia R. Sayer MR, et al. Among authors: mambetsariev i. Front Oncol. 2023 Feb 13;13:1064169. doi: 10.3389/fonc.2023.1064169. eCollection 2023. Front Oncol. 2023. PMID: 36860308 Free PMC article.
Integration of artificial intelligence in lung cancer: Rise of the machine.
Ladbury C, Amini A, Govindarajan A, Mambetsariev I, Raz DJ, Massarelli E, Williams T, Rodin A, Salgia R. Ladbury C, et al. Among authors: mambetsariev i. Cell Rep Med. 2023 Feb 21;4(2):100933. doi: 10.1016/j.xcrm.2023.100933. Epub 2023 Feb 3. Cell Rep Med. 2023. PMID: 36738739 Free PMC article. Review.
62 results